Chroma Therapeutics
Latest round
- Series D
Last raised
- Jun 2009
Total raised
- $103M
Investors
- 6
About Chroma Therapeutics
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches.
Who invested in Chroma Therapeutics
6 investors across 3 rounds
See all investors in Chroma Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chroma Therapeutics
Who invested in Chroma Therapeutics?
Chroma Therapeutics has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chroma Therapeutics raised?
Chroma Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Chroma Therapeutics last raise money?
Chroma Therapeutics's most recent round on record is a Series D, in Jun 2009.
What does Chroma Therapeutics do?
Chroma Therapeutics is a privately-held biotechnology company focused on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches.
Where is Chroma Therapeutics headquartered?
Chroma Therapeutics is headquartered in Abingdon, UK.
Which VCs invest in companies like Chroma Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Chroma Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Chroma Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.